Lorazepam Has Negative Impact on Survival in Pancreatic Cancer

TUESDAY, Aug. 22, 2023 -- Lorazepam stimulates fibrosis and inflammatory signaling and is associated with reduced survival in patients with pancreatic cancer, according to a study published online Aug. 17 in Clinical Cancer Research. Abigail C....
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news